Cost-effectiveness of antiosteoporosis strategies for postmenopausal women with osteoporosis in China
Conclusion:
From the perspective of the Chinese medical system, zoledronate is more cost-effective than the calcium/vitamin D strategy, alendronate, raloxifene, and teriparatide for the treatment of osteoporosis in elderly postmenopausal women. Not factoring the parameters of adherence and persistence in, and consequent variability in treatment effectiveness relative risks, seems like a major limitation, but it can be speculated that it would not change the conclusion that zoledronate is the most economical strategy.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Calcium | China Health | Epidemiology | Evista | Forteo | International Medicine & Public Health | Men | Menopause | OBGYN | Orthopaedics | Osteoporosis | Study | Vitamin D | Vitamins | Women